GlycanAge identified 16 genes that control IgG glycosylation in a large genome-wide study.
Public source
Publisher name
Public post
We identified 16 genes that control IgG glycosylation. And rather than only being tied to immune health, most link to disease. Immunoglobulin G does not get its glycan s…
Company
GlycanAge
Measure your real health. Predict your future health. Discover your bio-age with a test backed by 350+ research studies
- Industry
- Biotechnology
- Location
- Newcastle upon Tyne, GB
- Company size
- 11–50 employees
About GlycanAge
At GlycanAge, we’re redefining the way we understand and measure aging. Backed by over 30 years of research and more than 300 peer-reviewed publications, our work centers on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers offer a unique lens into your biological age, helping us understand how lifestyle, chronic inflammation, and environmental factors influence the aging process. Our flagship product, the GlycanAge® test, is a simple at-home test that goes beyond genetics to show how your body is actually aging—right now. It's already used by over 1,500 providers and tens of thousands of customers globally to track the impact of interventions and optimise preventative care strategies. Whether you're leading in the longevity space or taking the first step in your health journey, GlycanAge empowers you with actionable insights to live healthier for longer.
See moreLatest activity
Latest activity from GlycanAge
16 signals
Presence & Recognition
GlycanAge is hosting a live webinar on Thusday featuring Dr. Stephen Sideroff to discuss resilience and recovery.
Research & Knowledge
GlycanAge tested testosterone therapy in men against IgG glycosylation and GlycanAge in the same research program, finding a clear shift toward a younger glycan profile with reduced agalactosylation and increased galactosylation and sialylation.
Research & Knowledge
GlycanAge tested metformin in the same research program as testosterone therapy in men, finding that metformin showed no significant effect on glycosylation or GlycanAge in the vast majority of people tested.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
BioAgeDiagnostics
BioAgeDiagnostics published a new article exploring the science, clinical applications, and limitations of pharmacogenetic testing.
Research & Knowledge
Infinity Bio, Inc.
Infinity Bio, Inc. published a study in Nature Communications by von Stemann and colleagues mapping the genetic architecture of anti-cytokine autoantibodies across ~15,000 participants from the Danish Blood Donor Study and evaluating disease associations across 300,000 individuals in the Copenhagen Hospital Biobank.
Research & Knowledge
Jinfiniti Precision Medicine
Jinfiniti Precision Medicine published a 2025 study following 170 older adults grouped as robust, pre-frail, or frail to measure B vitamins, homocysteine, and global DNA methylation.
Research & Knowledge
Thermo Fisher Scientific
Thermo Fisher Scientific published a study in Nature Biotechnology demonstrating how proteomic aging clocks can be integrated into clinical trials using six existing proteomic clocks and longitudinal serum proteomics from a Phase 2a study.
Research & Knowledge
Sanford Burnham Prebys